An agreement between Johns Hopkins University and the Coalition for Epidemic Preparedness Innovations U.S. (CEPI U.S.) positions the two organizations for a new collaboration and for research and practice opportunities related to the pursuit of new vaccines for unmet infectious disease threats.
The agreement was recently signed and will last five years.
Cooperative work will be led by the Center for Health Security, the Center for Immunization Research, and the Johns Hopkins Vaccine Initiative at the Johns Hopkins Bloomberg School of Public Health. Activities to be considered include potential research collaborations, professional development activities through CEPI U.S.’s partners’ network and Johns Hopkins schools, student internship and externship opportunities at CEPI U.S., co-hosting of CEPI U.S. conferences and professional meetings on campus, and other opportunities as they arise.
Launched in 2017, CEPI is an alliance among governments, industry, academia, philanthropy, intergovernmental institutions, and civil society whose mission is to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics, with a focus on vaccine access in low-income countries. CEPI pledges to ensure that vaccines play the fullest possible part in containing infections with epidemic potential, to prevent them from becoming public health emergencies, and to build a safer world. CEPI U.S. is part of CEPI.